Literature DB >> 173486

E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance.

H M Anthony, J A Kirk, K E Madsen, M K Mason, G H Templeman.   

Abstract

Using peripheral blood lymphocytes separated by a Ficoll method and suspended in saline, means of 77-1% (s.d. 5-2) E rosettes (T lymphocytes) and 20-1% (s.d. 6-7) EAC rosettes (B lymphocytes) have been obtained with normal healthy donors. Poorer E-rosette formation resulted from higher centrifugation speeds during the washing of lymphocytes or erythrocytes, insufficient chilling, or rough handling. The presence of 5% albumin in the final mixture stabilized the rosettes and brought a constant subpopulation of B lymphocytes into rosetting. In patients with bronchial carcinoma who, at the time of diagnosis, had E-rosette percentages below 1 s.d. of the mean for normal donors, the length of survival was significantly shorter than in those with normal or high values. The same was true for those in whom null cells were detected. In each case the correlation effect was mainly found in the group of patients with squamous carcinoma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173486      PMCID: PMC1538183     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes.

Authors:  S S Fröland
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

2.  Inhibition of human lymphocyte rosetting by anti-T sera.

Authors:  H H Worth; A G Cooper; M C Brown
Journal:  Nat New Biol       Date:  1973-05-23

3.  Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction.

Authors:  Z Bentwich; S D Douglas; F P Siegal; H G Kunkel
Journal:  Clin Immunol Immunopathol       Date:  1973-07

4.  Inhibition of complement-dependent lymphocyte rosette formation: a possible test for activated complement products.

Authors:  G Ezer; A R Hayward
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

5.  The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.

Authors:  H M Anthony; G H Templeman; K E Madsen; M K Mason
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

6.  Immunologic alterations in bronchogenic cancer. Sequential study.

Authors:  M J Krant; G Manskopf; C S Brandrup; M A Madoff
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

7.  Rosetting of human red blood cells to thymocytes and thymus-derived cells.

Authors:  G Baxley; G B Bishop; A G Cooper; H H Wortis
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

8.  Studies of peripheral blood T-and B-lymphocytes in acute infections.

Authors:  P M Niklasson; R C Williams
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

9.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  11 in total

1.  The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.

Authors:  H Verhaegen; W De Cock; J De Cree
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Lymphocyte subpopulations in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

3.  Total T lymphocytes in primary bronchial carcinoma.

Authors:  H L Roberts; W T Donohoe; S Hewitt; D A Price Evans
Journal:  Thorax       Date:  1977-02       Impact factor: 9.139

4.  Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  [Immune status of patients with bronchial cancer].

Authors:  P Aulenbacher; H G Manke; P Drings
Journal:  Klin Wochenschr       Date:  1987-05-15

6.  Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

Authors:  H S Shukla; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

7.  E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.

Authors:  H M Anthony; J A Kirk; K E Madsen; M K Mason; G H Templeman
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

8.  Immunological state of patients with carcinoma of the bronchus before and after radiotherapy.

Authors:  A M Savage; J A Pritchard; T J Deeley; B H Davies
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

9.  Tissue T and B cell infiltration of primary and metastatic cancer.

Authors:  G Husby; P M Hoagland; R G Strickland; R C Williams
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

10.  Relative and absolute numbers of E- and EAC-rosette-forming cells in lymphoid organs.

Authors:  R Pabst; E Kaupp; F Trepel
Journal:  Blut       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.